ABIOMED Analysis
ABIOMED is undervalued with Real Value of 0.0 and Hype Value of 0.0. The main objective of ABIOMED delisted stock analysis is to determine its intrinsic value, which is an estimate of what ABIOMED is worth, separate from its market price. There are two main types of ABIOMED's stock analysis: fundamental analysis and technical analysis.
The ABIOMED stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and ABIOMED's ongoing operational relationships across important fundamental and technical indicators.
ABIOMED |
ABIOMED Stock Analysis Notes
About 97.0% of the company shares are held by institutions such as insurance companies. The company has Price/Earnings To Growth (PEG) ratio of 2.75. ABIOMED recorded earning per share (EPS) of 5.83. The entity last dividend was issued on the 29th of October 2010. The firm had 2:1 split on the 2nd of October 2000. Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. The company was founded in 1981 and is headquartered in Danvers, Massachusetts. Abiomed operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 2003 people. For more info on ABIOMED please contact Michael Minogue at 978 777-8411 or go to www.abiomed.com.ABIOMED Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more delisted stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. ABIOMED's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding ABIOMED or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
ABIOMED is not yet fully synchronised with the market data | |
ABIOMED has some characteristics of a very speculative penny stock | |
ABIOMED has a very high chance of going through financial distress in the upcoming years | |
Over 97.0% of the company shares are held by institutions such as insurance companies |
ABIOMED Thematic Classifications
In addition to having ABIOMED stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
Obamacare RepealLarge healthcare related equities associated with Obamacare | ||
ObamacareCompanies that count on Obamacare to take off |
ABIOMED Market Capitalization
The company currently falls under 'Large-Cap' category with a current market capitalization of 17.18 B.ABIOMED Profitablity
The company has Profit Margin (PM) of 0.25 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.23 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.23.ABIOMED Outstanding Bonds
ABIOMED issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. ABIOMED uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most ABIOMED bonds can be classified according to their maturity, which is the date when ABIOMED has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
Dana 575 percent Corp BondUS235822AB96 | View | |
Volcan Compania Minera Corp BondUSP98047AC08 | View | |
Boeing Co 2196 Corp BondUS097023DG73 | View | |
MPLX LP 4875 Corp BondUS55336VAG59 | View | |
MPLX LP 4125 Corp BondUS55336VAK61 | View | |
MPLX LP 52 Corp BondUS55336VAL45 | View | |
Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
Morgan Stanley 3971 Corp BondUS61744YAL20 | View |
ABIOMED Technical and Predictive Indicators
Risk Adjusted Performance | 0.129 | |||
Market Risk Adjusted Performance | (1.42) | |||
Mean Deviation | 0.1065 | |||
Downside Deviation | 0.1138 | |||
Coefficient Of Variation | 455.97 | |||
Standard Deviation | 0.1831 | |||
Variance | 0.0335 | |||
Information Ratio | (0.46) | |||
Jensen Alpha | 0.0326 | |||
Total Risk Alpha | 0.0011 | |||
Sortino Ratio | (0.74) | |||
Treynor Ratio | (1.43) | |||
Maximum Drawdown | 0.9779 | |||
Value At Risk | (0.13) | |||
Potential Upside | 0.2704 | |||
Downside Variance | 0.0129 | |||
Semi Variance | (0.04) | |||
Expected Short fall | (0.18) | |||
Skewness | 2.99 | |||
Kurtosis | 11.53 |
Risk Adjusted Performance | 0.129 | |||
Market Risk Adjusted Performance | (1.42) | |||
Mean Deviation | 0.1065 | |||
Downside Deviation | 0.1138 | |||
Coefficient Of Variation | 455.97 | |||
Standard Deviation | 0.1831 | |||
Variance | 0.0335 | |||
Information Ratio | (0.46) | |||
Jensen Alpha | 0.0326 | |||
Total Risk Alpha | 0.0011 | |||
Sortino Ratio | (0.74) | |||
Treynor Ratio | (1.43) | |||
Maximum Drawdown | 0.9779 | |||
Value At Risk | (0.13) | |||
Potential Upside | 0.2704 | |||
Downside Variance | 0.0129 | |||
Semi Variance | (0.04) | |||
Expected Short fall | (0.18) | |||
Skewness | 2.99 | |||
Kurtosis | 11.53 |
About ABIOMED Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how ABIOMED prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling ABIOMED shares will generate the highest return on investment. We also built our delisted stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Delisted Stock such as ABIOMED. By using and applying ABIOMED Stock analysis, traders can create a robust methodology for identifying ABIOMED entry and exit points for their positions.
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. The company was founded in 1981 and is headquartered in Danvers, Massachusetts. Abiomed operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 2003 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding ABIOMED to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Efficient Frontier Now
Efficient FrontierPlot and analyze your portfolio and positions against risk-return landscape of the market. |
All Next | Launch Module |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Other Consideration for investing in ABIOMED Stock
If you are still planning to invest in ABIOMED check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the ABIOMED's history and understand the potential risks before investing.
Stocks Directory Find actively traded stocks across global markets | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |